News

Investors

Careers

Contacts

PUBLICATIONS AND PRESENTATIONS

Publications - All Dates

Frontiers in Psychiatry - 06/23/2023

Serdexmethylphenidate/dexmethylphenidate effects on sleep in children with attention-deficit/hyperactivity disorder

Poster Presentations - All Dates

22nd Annual WORLDSymposium - 02/03/2026

Efficacy of Arimoclomol Combined With Miglustat at Months 3, 6, 9 and 12 of the Double-Blind, Randomized, Placebo-Controlled NPC002 Trial

22nd Annual WORLDSymposium - 02/03/2026

Multi-year subgroup analyses of Niemann-Pick disease type C participantstreated with arimoclomol in the US early access program (EAP)

22nd Annual WORLDSymposium - 02/03/2026

Real-world safety and effectiveness arimoclomol in patients with NPC:outcomes from the US early access program (EAP) over a 4-year period

22nd Annual WORLDSymposium - 02/03/2026

Long-term safety and effectiveness of arimoclomol adult and pediatricNiemann-Pick disease type C patients in the US early access program (EAP)

Sleep Europe - 09/27/2024

Safety and Efficacy of KP1077 in a Phase 2, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Patients with Idiopathic Hypersomnia

Sleep Europe - 09/26/2024

Safety and Efficacy of KP1077 in a Phase 2, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Patients with Idiopathic Hypersomnia

SLEEP 2024 Annual Meeting - 06/03/2024

Safety and Efficacy of KP1077 in a Phase 2, Double-blind, Randomized Trial in Patients With Idiopathic Hypersomnia

SLEEP 2024 Annual Meeting - 06/03/2024

Pharmacokinetics of Morning and Nighttime Doses of KP1077, an Investigational Treatment for Idiopathic Hypersomnia

Beyond Sleepy 2024 Annual Meeting - 06/01/2024

A Novel Investigational Treatment for Hypersomnia: Where We Are and Where We Need to Go

Psych Congress 2023 - 09/09/23

Cardiovascular (CV) Safety and Pharmacokinetics (PK) of Serdexmethylphenidate (SDX), a Prodrug of d-Methylphenidate (d-MPH) Compared to Ritalin and Ritalin LA in a Single-Dose Crossover Study in Healthy Volunteers

Beyond Sleepy 2023 Conference - 06/04/23

A Clinical Study with KP1077 in Adults with Idiopathic Hypersomnia

Poster Presentations - 2026

22nd Annual WORLDSymposium - 02/03/2026

Long-term safety and effectiveness of arimoclomol adult and pediatricNiemann-Pick disease type C patients in the US early access program (EAP)

22nd Annual WORLDSymposium - 02/03/2026

Real-world safety and effectiveness arimoclomol in patients with NPC:outcomes from the US early access program (EAP) over a 4-year period

22nd Annual WORLDSymposium - 02/03/2026

Multi-year subgroup analyses of Niemann-Pick disease type C participantstreated with arimoclomol in the US early access program (EAP)

22nd Annual WORLDSymposium - 02/03/2026

Efficacy of Arimoclomol Combined With Miglustat at Months 3, 6, 9 and 12 of the Double-Blind, Randomized, Placebo-Controlled NPC002 Trial

Poster Presentations - 2025 to 2024

Sleep Europe - 09/27/2024

Safety and Efficacy of KP1077 in a Phase 2, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Patients with Idiopathic Hypersomnia

Sleep Europe - 09/26/2024

Safety and Efficacy of KP1077 in a Phase 2, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Patients with Idiopathic Hypersomnia

SLEEP 2024 Annual Meeting - 06/03/2024

Safety and Efficacy of KP1077 in a Phase 2, Double-blind, Randomized Trial in Patients With Idiopathic Hypersomnia

SLEEP 2024 Annual Meeting - 06/03/2024

Pharmacokinetics of Morning and Nighttime Doses of KP1077, an Investigational Treatment for Idiopathic Hypersomnia

Beyond Sleepy 2024 Annual Meeting - 06/01/2024

A Novel Investigational Treatment for Hypersomnia: Where We Are and Where We Need to Go

Publications - 2023 to 2022

- 06/23/2023

Serdexmethylphenidate/dexmethylphenidate effects on sleep in children with attention-deficit/hyperactivity disorder

Poster Presentations - 2023 to 2022

Psych Congress 2023 - 09/09/23

Cardiovascular (CV) Safety and Pharmacokinetics (PK) of Serdexmethylphenidate (SDX), a Prodrug of d-Methylphenidate (d-MPH) Compared to Ritalin and Ritalin LA in a Single-Dose Crossover Study in Healthy Volunteers

Beyond Sleepy 2023 Conference - 06/04/23